1.0CNATMhttps://cnatm.de/en2024 Nobel Prize for microRNA - CNATMrich600338<blockquote class="wp-embedded-content" data-secret="xVxm607Ul0"><a href="https://cnatm.de/en/2024-nobel-prize-for-microrna/">2024 Nobel Prize for microRNA</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://cnatm.de/en/2024-nobel-prize-for-microrna/embed/#?secret=xVxm607Ul0" width="600" height="338" title="“2024 Nobel Prize for microRNA” — CNATM" data-secret="xVxm607Ul0" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script>
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://cnatm.de/wp-includes/js/wp-embed.min.js
</script>https://cnatm.de/wp-content/uploads/2024/08/News_Beitragsbild.png945445Victor Ambros and Gary Ruvkun have been awarded the 2024 Nobel Prize for theirdiscovery of the first microRNA, lin-4, in C. elegans. This is the second consecutive Nobel Prize for nucleic acids, following the 2023 Nobel Prize for Katalin Karikó and Drew Weissmann for their work onmRNA technology. The development of nucleic acid-based therapeutics is the goal of the Cluster for Nucleic Acid Therapeutics Munich (CNATM). In CNATM leading academic groups and 14 biotech companies are working together to achieve this goal. Several CNATM partners are focusing on microRNA-based therapeutics (rnatics GmbH, Secarna Pharmaceuticals GmbH, Engelhardt Group at the Institut for Pharmacology and Toxikology at TUM, Yildirim Group at the Helmholtz München).